Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACORD: NeoRecormon in Early Diabetic Nephropathy
NCT00354341Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2002
- Primary completion
- Jul 2005
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 17
01
Overview
A Phase 3 trial of epoetin beta in anemia, sponsored by Roche. Started Sep 2002; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00354341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354341.